Company Overview
We envision a day when everyone has access to safe, effective, and affordable biopharmaceuticals.
At Tanvex, we develop and manufacture biopharmaceuticals specializing in biosimilars, an affordable alternative to products currently on the market. Biosimilars offer increased treatment options and access to lifesaving medications.
Our work honors the promise to help more people live healthier lives. Tanvex aims to lower medical costs – because everyone deserves health.
Our Mission
- Drive greater good through safe, effective, and affordable biopharmaceuticals
- Employ talented and passionate individuals who contribute to our vision
- Create strong partnerships to offer competitive advantages from development through regulatory approval and commercialization
-
Teamwork
-
TenAcity
-
iNnovation
-
diVersity
-
empowerment
-
eXcellence
Our Journey
Tanvex was born from a legacy, and is now inspired by a bright future laser-focused on helping more and more people get access to high-quality medicine.
Tanvex was born from a legacy. In 1984, Dr. Allen Chao transformed the healthcare system as a pioneer for generic drugs. As the founder and visionary of Watson Pharmaceuticals, he was on a mission to drive down the cost of prescription drugs and expand their availability to millions of patients who could not afford their needed medications. The impact of these contributions endures, with generics saving the US healthcare system over $4 trillion in the past two decades.*
More than thirty years later, we are proud to announce that this transformation continues at Tanvex. Today, with the foundation established by Dr. Chao, our dedicated employees, and leaders as a team are applying the same passion for creating a new generation of affordable drugs: biosimilars. The production of high-quality biologics and biosimilars in large quantities has been a complex challenge, contributing to high costs. But now, with efficient in-house manufacturing and innovative processes, Tanvex is reshaping the biopharmaceutical industry to lower costs and deliver more value.
We are proud of our legacy and our global team—which drives our daily efforts to grant more patients access to safe, effective, and affordable high-quality medicine.
*Data on fileLeadership
